CD3 receptor complex (CD3)

The CD3 receptor complex is a critical T-cell–associated effector target composed of several distinct polypeptide chains (epsilon, gamma, delta, and zeta) that associate with the T-cell receptor (TCR). Its primary biological function is to transmit activation signals to the T-cell's interior following the recognition of an antigen by the TCR, thereby initiating an adaptive immune response. In healthy individuals, CD3 is essential for T-cell development and the maintenance of immune homeostasis. In the context of disease, CD3 is a primary target for therapeutic intervention in both oncology and immunology. In oncology, bispecific antibodies utilize CD3 to physically bridge cytotoxic T-cells to tumor cells, bypassing the need for traditional MHC-restricted antigen presentation to induce tumor lysis. Conversely, in autoimmune diseases and organ transplantation, anti-CD3 antibodies are used to modulate or deplete T-cell populations to prevent tissue rejection or self-attack. The clinical use of CD3-targeting agents is highly effective but requires careful management of systemic inflammatory responses, such as cytokine release syndrome, which results from the potent activation of the immune system.

Other names

Cluster of differentiation 3T-cell receptor-CD3 complexT-cell surface glycoprotein CD3CD3 epsilonCD3 deltaCD3 gammaCD3 zeta

CD3 is targeted by monoclonal antibodies and bispecific T-cell engagers (BiTEs) to either suppress T-cell activity in autoimmune conditions or to redirect T-cell cytotoxicity toward specific tumor cells by cross-linking the CD3 complex with tumor-associated antigens.